🕒 Created

Boston Scientific reports a major cyberattack causing global disruptions to its medical device operations.

Boston Scientific confirmed in a federal regulatory filing that a cyberattack has caused significant disruptions to its IT systems and business applications. The Massachusetts-based medical device maker, which produces implants like pacemakers and defibrillators, reported that the incident has impaired its ability to process and ship customer orders worldwide. While the company is working diligently to restore affected functions, a specific timeline for full restoration is not yet known. Analysts at Piper Sandler suggest it may take several weeks before the company can resume normal business operations. The cyberattack has already impacted the company's stock price, with shares falling 4.5% following the disclosure. This incident highlights the company's dependence on centralized IT systems for global order processing. While the attack does not directly affect the clinical performance of its products, it underscores the operational risks and compliance pressures facing the company as it works to harden its systems against future cyber threats.

Sources